• Tech Solution

    The Oxford/AstraZeneca vaccine will be tested in a new trial after questions over its data

    However, the 90{69439eabc38bbe67fb47fc503d1b0f790fcef507f9cafca8a4ef4fbfe163a7c5} claim came into question after it was pointed out the vaccine’s overall efficacy was 62 to 70{69439eabc38bbe67fb47fc503d1b0f790fcef507f9cafca8a4ef4fbfe163a7c5} in trials in Brazil and in the UK, while the 90{69439eabc38bbe67fb47fc503d1b0f790fcef507f9cafca8a4ef4fbfe163a7c5} figure was reached only among fewer than 3,000 participants who were given a lower dose as a result of an error. Researchers can’t explain why the accidental lower dose proved more effective. So AstraZeneca plans to run another trial, testing just this lower-dose regimen. “Now that we’ve found what looks like a better efficacy we have to validate this, so we need to do an additional study,” Soriot … Read More

    Comments Off on The Oxford/AstraZeneca vaccine will be tested in a new trial after questions over its data
  • News

    Facebook’s Libra could launch in January – TechCrunch

    According to a report from the Financial Times, Facebook-backed cryptocurrency Libra could launch in January. More interestingly, the Libra Association, the consortium created by Facebook, could scale back its ambitions once again. When it was first unveiled, the Libra cryptocurrency was supposed to be a brand new currency tied to a basket of fiat currencies and securities. Originally, it wouldn’t be based on a single real world currency, but on a mix of multiple currencies. Many central banks and regulators have been concerned about this vision. That’s why the Libra Association changed course and started working on several single-currency … Read More

    Comments Off on Facebook’s Libra could launch in January – TechCrunch